Thermo Fisher Scientific Stock To Go Ex-dividend Tomorrow (TMO)

NEW YORK ( TheStreet) -- The ex-dividend date for Thermo Fisher Scientific (NYSE: TMO) is tomorrow, March 13, 2012. Owners of shares as of market close today will be eligible for a dividend of 13 cents per share. At a price of $56.26 as of 9:30 a.m. ET, the dividend yield is 0.9%.

The average volume for Thermo Fisher Scientific has been 3.3 million shares per day over the past 30 days. Thermo Fisher Scientific has a market cap of $19.85 billion and is part of the health care sector and health services industry. Shares are up 25.1% year to date as of the close of trading on Friday.

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. The company has a P/E ratio of 21.2, above the average health services industry P/E ratio of 20 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, attractive valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Thermo Fisher Scientific Ratings Report.

See our dividend calendar or top-yielding stocks list.
null

If you liked this article you might like

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR